GSK Establishes Discovery Unit For Traditional Chinese Medicine
This article was originally published in PharmAsia News
Executive Summary
GSK transforms DPU in Shanghai into TCM discovery unit that will consist of a small number of select scientists with both Western drug discovery experience and TCM knowledge.
You may also be interested in...
GSK Says R&D Productivity Up, But Story Is About Culture, Not Numbers
At its latest R&D review, GSK has culled three of its biotech-like discovery performance units and created four new ones. But less important than the numbers is the new culture, claims CEO Andrew Witty
Novo Nordisk Fights Back Dipping Sales In China By Expanding R&D, Manufacturing Capacity
BEIJING - Diabetes-focused Danish firm Novo Nordisk A/S is not deterred by a dip in China sales, and is planning to expand its R&D center and manufacturing capability in China to maintain its leading position in the country
GlaxoSmithKline R&D Under Scrutiny In Bid For Fresh Funding
It's crunch time for GlaxoSmithKline PLC's 38 biotech-like R&D units, which are competing for further funding as they reach the end of their first three-year investment cycle.